Categories
Pharmaceutical

Demand for Blood Cancer Diagnostics CBC Tests in Independent Diagnostic Laboratories has seen a Major Boost

250 Pages Blood Cancer Diagnostics CBC Tests Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Blood Cancer Diagnostics CBC Tests to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Blood Cancer Diagnostics CBC Tests market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=47

Fact.MR has recently updated its analysis of the global Blood Cancer Diagnostics CBC Tests market, and reveals that rising number of affected people and increasing spending on the healthcare sector are the two prime factors driving demand for Blood Cancer Diagnostics CBC Tests. As per the detailed study, the worldwide cancer diagnostics market is anticipated to rise at a healthy CAGR of 6% over the next ten years.

Global Market CAGR 6% (2021-2031)
North America Revenue Share 40%
Liquid Biopsy Segment CAGR 9%

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Blood Cancer Diagnostics CBC Tests market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Blood Cancer Diagnostics CBC Tests

The report offers actionable and valuable market insights of Blood Cancer Diagnostics CBC Tests. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Blood Cancer Diagnostics CBC Tests Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=47

Key Segments Covered in Blood Cancer Diagnostics CBC Tests Industry Survey

  • By Test

    • CBC Tests for Blood Cancer Diagnostics CBC Tests
    • CTC Tests for Blood Cancer Diagnostics CBC Tests
    • Blood Protein Testing for Blood Cancer Diagnostics CBC Tests
    • Liquid Biopsy for Blood Cancer Diagnostics CBC Tests
    • Bone Marrow Biopsy for Blood Cancer Diagnostics CBC Tests

  • By End User

    • Blood Cancer Diagnostics CBC Tests In Hospital Associated Labs
    • Blood Cancer Diagnostics CBC Tests In Independent Diagnostic Laboratories
    • Blood Cancer Diagnostics CBC Tests In Cancer Research Institutes
    • Others

Competitive Landscape

Leading players in the Blood Cancer Diagnostics CBC Tests market are focussing on developing new products and diagnostic methods to optimize the process of diagnosis and testing.

Latest innovations in Blood Cancer Diagnostics CBC Tests are allowing market players to craft unique and standard solutions that would be compliant with healthcare standards across the globe.

  • In July 2021, Biofidelity Ltd., a renowned name in cancer diagnostics, announced the opening of its U.S. headquarters in North Carolina. The site will be home to the company’s breakthrough ASPYRE technology, which helps laboratories, oncologists, and pharmaceutical companies to perform tests.
  • NHS England will be running a pilot trial with Galleri test developed by GRAIL a medtech company based in the U.S. The test utilizes a machine learning algorithm that can detect more than fifty types of cancers before the emergence of their clinical symptoms.
  • In May 2021, Burning Rock Biotech Limited announced the launch of the first blood-based pan-cancer study in China, which is based on a multi-omics approach. The study is dubbed as PRESCIENT (Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT).

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/47

Fact.MR, in its recent research, offers market forecast and analysis on the Blood Cancer Diagnostics CBC Tests market for the period, 2017-2022. According to the research, the global Blood Cancer Diagnostics CBC Tests market is projected to grow at 6.4% CAGR through 2022. The key takeaways from Fact.MR’s research report include,

  • By test type, the CBC segment, which is currently valued at nearly US$ 77 million, is projected to grow at nearly 5% CAGR. In the North America Blood Cancer Diagnostics CBC Tests market, these tests will continue to account for a significant share of overall revenues.
  • Owing to highly accurate diagnosis, blood testing will also continue to be a widely used test globally. Fact.MR projects this segment to rake in significant revenues by 2022.
  • On back of recent reports about the accuracy and benefits of using liquid biopsy, this segment is gaining traction globally. Research carried out at Massachusetts General Hospital Cancer Center and Harvard Medical School has shown that liquid biopsy can help patients with advanced cholangiocarcinoma. Fact.MR projects this segment to grow at a high CAGR through 2022.
  • The bone marrow test type is also being widely used by end-users owing to its efficacy in diagnosis and management. According to Fact.MR’s analysis, the bone marrow test type is anticipated to rake in significant revenues during the forecast period. Revenues from this segment are anticipated to grow at a healthy CAGR through 2022.
  • Hospital associated labs account for a significant revenue share of the overall demand for Blood Cancer Diagnostics CBC Tests. According to Fact.MR’s analysis, this end-use segment is projected to grow at over 6% CAGR through 2022.
  • Independent diagnostic laboratories are also a major end-user of Blood Cancer Diagnostics CBC Tests. Fact.MR estimates revenues from this segment to grow at over 6% CAGR through 2022. Demand is also anticipated to be strong from the cancer research institutes segment.
  • The Blood Cancer Diagnostics CBC Tests market in the U.S. will continue to account for a significant share of the global revenues. The U.S. will also remain significant owing to R&D and new developments in diagnostics. Fact.MR projects the U.S. Blood Cancer Diagnostics CBC Tests market to account for leading revenue share of the global market.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Blood Cancer Diagnostics CBC Tests Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Blood Cancer Diagnostics CBC Tests Historical volume analysis: The report provides a comparison of Blood Cancer Diagnostics CBC Tests’s historical sales and projected sales performance for 2021-2031.
  • Blood Cancer Diagnostics CBC Tests Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Blood Cancer Diagnostics CBC Tests market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Blood Cancer Diagnostics CBC Tests Consumption by demographics: The report investigates consumer behavior affecting Blood Cancer Diagnostics CBC Tests demand outlook for the assessment period. Effect of their keenness for digital trends on Blood Cancer Diagnostics CBC Tests market is carefully analyzed
  • Post COVID consumer spending on Blood Cancer Diagnostics CBC Tests: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Blood Cancer Diagnostics CBC Tests market growth.

More Valuable Insights on Blood Cancer Diagnostics CBC Tests Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Blood Cancer Diagnostics CBC Tests, Sales and Demand of Blood Cancer Diagnostics CBC Tests, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates